CCT - Crypto Currency Tracker logo CCT - Crypto Currency Tracker logo
CoinDesk 2025-10-02 14:03:26

Crypto Market Maker GSR to Acquire FINRA-Registered Broker-Dealer Equilibrium Capital Services

Cryptocurrency market maker GSR has signed an agreement to acquire Equilibrium Capital Services, a Portland-based broker-dealer registered with the SEC and a member of FINRA. The deal, which is still pending regulatory approval, marks a step toward expanding GSR’s regulated presence in the United States. GSR did not disclose the terms of the Equilibrium Capital deal in its press release. Equilibrium Capital’s registration allows it to provide brokerage services under U.S. securities laws. By bringing it under its umbrella, GSR expects to offer institutional clients a more direct route into digital assets while operating within established compliance frameworks. GSR executives framed the move as part of a longer-term strategy to deepen its institutional ties in the U.S. Xin Song, the firm’s CEO, said the acquisition reflects GSR’s commitment to serving both entrepreneurs and large investors who want regulated access to crypto markets. The acquisition comes as regulators continue to shape the rules governing digital assets in the U.S. For a firm like GSR — best known for its global market-making and liquidity services — having a broker-dealer license could open doors to products that fall under securities oversight. To manage the acquisition process, GSR engaged Compliance Exchange Group (CXG) for regulatory guidance and BrokerDealerForSale.com for the acquisition of Equilibrium Capital Services. GSR has been steadily building its regulated services portfolio. In recent months, the firm has expanded institutional access to tokenized real-world assets through a partnership with DigiFT, according to a press release. The market making firm also invested in Maverix Securities to support the development of regulated structured products, and led digital-asset treasury investment strategies for Nasdaq-listed companies, including MEI Pharma and Upexi.

Leggi la dichiarazione di non responsabilità : Tutti i contenuti forniti nel nostro sito Web, i siti con collegamento ipertestuale, le applicazioni associate, i forum, i blog, gli account dei social media e altre piattaforme ("Sito") sono solo per le vostre informazioni generali, procurati da fonti di terze parti. Non rilasciamo alcuna garanzia di alcun tipo in relazione al nostro contenuto, incluso ma non limitato a accuratezza e aggiornamento. Nessuna parte del contenuto che forniamo costituisce consulenza finanziaria, consulenza legale o qualsiasi altra forma di consulenza intesa per la vostra specifica dipendenza per qualsiasi scopo. Qualsiasi uso o affidamento sui nostri contenuti è esclusivamente a proprio rischio e discrezione. Devi condurre la tua ricerca, rivedere, analizzare e verificare i nostri contenuti prima di fare affidamento su di essi. Il trading è un'attività altamente rischiosa che può portare a perdite importanti, pertanto si prega di consultare il proprio consulente finanziario prima di prendere qualsiasi decisione. Nessun contenuto sul nostro sito è pensato per essere una sollecitazione o un'offerta